Anticoagulants and Bleeding Disorders
Conditions
Brief summary
the investigators hypothesize that patients do not understand these therapies, and that they are poorly undertaken. In some cases, the anesthesiologist does not understand correctly the indication of the treatment due to lack of information and therefore does not know how to adapt it to the medical situation.
Detailed description
the investigators hypothesize that patients do not understand these therapies, and that they are poorly undertaken. In some cases, the anesthesiologist does not understand correctly the indication of the treatment due to lack of information and therefore does not know how to adapt it to the medical situation. the investigators want to investigate these transitions: how were they understood by patients, how were they performed, and how does this affect surgery, postoperative morbidity and mortality? Anticoagulation for prevention of thromboembolic events will not be studied in this study. The anesthesia team will not be particularly trained in anticoagulants and antiplatelets management to be close to actual care. In the Hospital the investigators have a guide written in 2013 in order to describe all the cases possible. The control/ goal group will be the patients who have undertaken strictly the protocol described for their cases in the guide.
Interventions
None listed
Sponsors
Erasme University Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
Yes
Inclusion criteria
* Patients over 18 years old * Able to consent * Taking anticoagulants or antiplatelet drugs in the long term.
Exclusion criteria
* Incapacitated adults * Minor patients
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Ratio of well treated patient | 30 days | Ratio of well treated patient |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| bleeding consequence (volume in mL) | 30 days | bleeding consequence (volume in mL) |
| Mortality Consequence | 30 Days | percentage of death |
| Blood Test Consequence | 30 Days | deviation in percentage on INR |
| Morbidity | 30 days | percentage of rehospitalisation |
Countries
Belgium
Outcome results
None listed